<?xml version="1.0" encoding="UTF-8"?>
<p>In Brazil, there are few seroprevalence studies; this does not allow the identification of the attack rate in different regions of viral circulation, and consequently, an estimation of the percentage of susceptible individuals in new epidemic outbreaks
 <xref rid="B8" ref-type="bibr">
  <sup>8</sup>
 </xref>
 <sup>,</sup>
 <xref rid="B9" ref-type="bibr">
  <sup>9</sup>
 </xref>. A study conducted in two cities in Bahia, which was the gateway for the virus in Brazil, identified attack rates of around 50%, with 40% of these patients becoming symptomatic in the acute phase of the disease
 <xref rid="B9" ref-type="bibr">
  <sup>9</sup>
 </xref>.
</p>
